The value of programmed death ligand 1 expression in cancer patients treated with neoadjuvant chemotherapy

Malika Al-Dughaishi, Asem Shalaby*, Khawla Al-Ribkhi, Ammar Boudaka, Mohamed Boulassel, Jumana Saleh

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The value of programmed death ligand 1 expression in cancer patients treated with neoadjuvant chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences